To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

NCT06552520 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: TQH2722 injection
DRUG: Placebo of TQH2722 injection

Sponsor

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.